{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T13:50:11Z","timestamp":1785333011290,"version":"3.55.0"},"reference-count":36,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1471,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,9,1]]},"DOI":"10.1111\/j.1476-5381.2011.01360.x","type":"journal-article","created":{"date-parts":[[2011,3,22]],"date-time":"2011-03-22T14:14:00Z","timestamp":1300803240000},"page":"372-381","source":"Crossref","is-referenced-by-count":40,"title":["Pyrrolidine dithiocarbamate down-regulates vascular matrix metalloproteinases and ameliorates vascular dysfunction and remodelling in renovascular hypertension"],"prefix":"10.1111","volume":"164","author":[{"given":"SBA","family":"Cau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DA","family":"Guimaraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Rizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CS","family":"Ceron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LL","family":"Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CR","family":"Tirapelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RF","family":"Gerlach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JE","family":"Tanus-Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,8,22]]},"reference":[{"key":"10.1111\/j.1476-5381.2011.01360.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1161\/01.HYP.37.2.781","article-title":"Long-term antioxidant administration attenuates mineralocorticoid hypertension and renal inflammatory response","volume":"37","author":"Beswick","year":"2001","journal-title":"Hypertension"},{"key":"10.1111\/j.1476-5381.2011.01360.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1089\/ars.2008.2390","article-title":"Cyclic stretch, reactive oxygen species, and vascular remodeling","volume":"11","author":"Birukov","year":"2009","journal-title":"Antioxid Redox Signal"},{"key":"10.1111\/j.1476-5381.2011.01360.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1161\/01.ATV.0000021412.56621.A2","article-title":"Vascular inflammation and the renin-angiotensin system","volume":"22","author":"Brasier","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/j.1476-5381.2011.01360.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1159\/000087451","article-title":"Angiotensin II stimulates matrix metalloproteinase secretion in human vascular smooth muscle cells via nuclear factor-kappaB and activator protein 1 in a redox-sensitive manner","volume":"42","author":"Browatzki","year":"2005","journal-title":"J Vasc Res"},{"key":"10.1111\/j.1476-5381.2011.01360.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1089\/ars.2008.2393","article-title":"Role of NF-kappaB in flow-induced vascular remodeling","volume":"11","author":"Castier","year":"2009","journal-title":"Antioxid Redox Signal"},{"key":"10.1111\/j.1476-5381.2011.01360.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.atherosclerosis.2007.10.011","article-title":"Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats","volume":"198","author":"Castro","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1111\/j.1476-5381.2011.01360.x-BIB8|cit7","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.freeradbiomed.2009.02.011","article-title":"Antioxidant treatment reduces matrix metalloproteinase-2-induced vascular changes in renovascular hypertension","volume":"46","author":"Castro","year":"2009","journal-title":"Free Radic Biol Med"},{"key":"10.1111\/j.1476-5381.2011.01360.x-BIB7|cit8","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.matbio.2009.11.005","article-title":"Imbalance between matrix metalloproteinases and tissue inhibitor of metalloproteinases in hypertensive vascular remodeling","volume":"29","author":"Castro","year":"2010","journal-title":"Matrix Biol"},{"key":"10.1111\/j.1476-5381.2011.01360.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/10409230701340019","article-title":"The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases","volume":"42","author":"Cauwe","year":"2007","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"10.1111\/j.1476-5381.2011.01360.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1476-5381.2010.00678.x","article-title":"Spironolactone and hydrochlorothiazide exert antioxidant effects and reduce vascular matrix metalloproteinase-2 activity and expression in a model of renovascular hypertension","volume":"160","author":"Ceron","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1111\/j.1476-5381.2011.01360.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/sj.bjp.0707344","article-title":"Acute actions and novel targets of matrix metalloproteinases in the heart and vasculature","volume":"152","author":"Chow","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1111\/j.1476-5381.2011.01360.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.biocel.2007.12.006","article-title":"The regulation of matrix metalloproteinases and their inhibitors","volume":"40","author":"Clark","year":"2008","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1111\/j.1476-5381.2011.01360.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1097\/00004872-200111000-00006","article-title":"Norepinephrine-induced aortic hyperplasia and extracellular matrix deposition are endothelin-dependent","volume":"19","author":"Dao","year":"2001","journal-title":"J Hypertens"},{"key":"10.1111\/j.1476-5381.2011.01360.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1161\/HYPERTENSIONAHA.107.089631","article-title":"Role of matrix metalloproteinases in early hypertensive vascular remodeling","volume":"50","author":"Flamant","year":"2007","journal-title":"Hypertension"},{"key":"10.1111\/j.1476-5381.2011.01360.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.regpep.2007.12.005","article-title":"Angiotensin II induces matrix metalloproteinase-9 expression via a nuclear factor-kappaB-dependent pathway in vascular smooth muscle cells","volume":"147","author":"Guo","year":"2008","journal-title":"Regul Pept"},{"key":"10.1111\/j.1476-5381.2011.01360.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1161\/CIRCRESAHA.107.150474","article-title":"Vascular endothelial cell-specific NF-kappaB suppression attenuates hypertension-induced renal damage","volume":"101","author":"Henke","year":"2007","journal-title":"Circ Res"},{"key":"10.1111\/j.1476-5381.2011.01360.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/sj.bjp.0703603","article-title":"Suppression of the development of hypertension by the inhibitor of inducible nitric oxide synthase","volume":"131","author":"Hong","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1111\/j.1476-5381.2011.01360.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/HYPERTENSIONAHA.107.103440","article-title":"Mechanisms of arterial remodeling in hypertension: coupled roles of wall shear and intramural stress","volume":"52","author":"Humphrey","year":"2008","journal-title":"Hypertension"},{"key":"10.1111\/j.1476-5381.2011.01360.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1161\/hy09t1.096249","article-title":"Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis","volume":"38","author":"Intengan","year":"2001","journal-title":"Hypertension"},{"key":"10.1111\/j.1476-5381.2011.01360.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/cvr\/cvp268","article-title":"Matrix metalloproteinase-2 and myocardial oxidative stress injury: beyond the matrix","volume":"85","author":"Kandasamy","year":"2010","journal-title":"Cardiovasc Res"},{"key":"10.1111\/j.1476-5381.2011.01360.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/01.RES.0000237388.89261.47","article-title":"Transforming growth factor-alpha mediates nuclear factor kappaB activation in strained arteries","volume":"99","author":"Lemarie","year":"2006","journal-title":"Circ Res"},{"key":"10.1111\/j.1476-5381.2011.01360.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.yjmcc.2009.09.018","article-title":"Extracellular matrix alterations in hypertensive vascular remodeling","volume":"48","author":"Lemarie","year":"2010","journal-title":"J Mol Cell Cardiol"},{"key":"10.1111\/j.1476-5381.2011.01360.x-BIB24|cit23","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ejphar.2008.06.096","article-title":"Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats","volume":"591","author":"Martinez","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/j.1476-5381.2011.01360.x-BIB23|cit24","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1161\/01.HYP.17.5.707","article-title":"Pathophysiology of renovascular hypertension","volume":"17","author":"Martinez-Maldonado","year":"1991","journal-title":"Hypertension"},{"issue":"1 Pt 2","key":"10.1111\/j.1476-5381.2011.01360.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1161\/01.HYP.35.1.193","article-title":"NF-kappaB inhibition ameliorates angiotensin II-induced inflammatory damage in rats","volume":"35","author":"Muller","year":"2000","journal-title":"Hypertension"},{"key":"10.1111\/j.1476-5381.2011.01360.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.mam.2008.05.002","article-title":"Progress in matrix metalloproteinase research","volume":"29","author":"Murphy","year":"2008","journal-title":"Mol Aspects Med"},{"key":"10.1111\/j.1476-5381.2011.01360.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.cardiores.2005.08.002","article-title":"Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates","volume":"69","author":"Newby","year":"2006","journal-title":"Cardiovasc Res"},{"key":"10.1111\/j.1476-5381.2011.01360.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.tips.2005.04.003","article-title":"Nitrosative stress and pharmacological modulation of heart failure","volume":"26","author":"Pacher","year":"2005","journal-title":"Trends Pharmacol Sci"},{"key":"10.1111\/j.1476-5381.2011.01360.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1124\/jpet.105.088062","article-title":"Early and sustained inhibition of nuclear factor-kappaB prevents hypertension in spontaneously hypertensive rats","volume":"315","author":"Rodriguez-Iturbe","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/j.1476-5381.2011.01360.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1084\/jem.175.5.1181","article-title":"Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells","volume":"175","author":"Schreck","year":"1992","journal-title":"J Exp Med"},{"key":"10.1111\/j.1476-5381.2011.01360.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0002-9440(10)64454-9","article-title":"Aldosterone-induced inflammation in the rat heart : role of oxidative stress","volume":"161","author":"Sun","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1111\/j.1476-5381.2011.01360.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1042\/CS20090557","article-title":"Role of nuclear factor kappaB in cardiovascular health and disease","volume":"118","author":"Van der Heiden","year":"2010","journal-title":"Clin Sci (Lond)"},{"key":"10.1111\/j.1476-5381.2011.01360.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"H2438","DOI":"10.1152\/ajpheart.00900.2006","article-title":"Morphological and biochemical characterization of remodeling in aorta and vena cava of DOCA-salt hypertensive rats","volume":"292","author":"Watts","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1111\/j.1476-5381.2011.01360.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1006\/jmcc.2002.2111","article-title":"NF-kappaB activation is essential for angiotensin II-dependent proliferation and migration of vascular smooth muscle cells","volume":"34","author":"Zahradka","year":"2002","journal-title":"J Mol Cell Cardiol"},{"key":"10.1111\/j.1476-5381.2011.01360.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1161\/01.RES.0000190589.52286.41","article-title":"Dual pathways for nuclear factor kappaB activation by angiotensin II in vascular smooth muscle: phosphorylation of p65 by IkappaB kinase and ribosomal kinase","volume":"97","author":"Zhang","year":"2005","journal-title":"Circ Res"},{"key":"10.1111\/j.1476-5381.2011.01360.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/HJH.0b013e3283340da8","article-title":"Vascular inflammation, insulin resistance, and endothelial dysfunction in salt-sensitive hypertension: role of nuclear factor kappa B activation","volume":"28","author":"Zhou","year":"2010","journal-title":"J Hypertens"}],"container-title":["British Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1476-5381.2011.01360.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1476-5381.2011.01360.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T15:04:34Z","timestamp":1625670274000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1476-5381.2011.01360.x"}},"subtitle":["PDTC down-regulates MMPs in hypertension"],"short-title":[],"issued":{"date-parts":[[2011,8,22]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,9,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01360.x","relation":{},"ISSN":["0007-1188"],"issn-type":[{"value":"0007-1188","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8,22]]}}}